To evaluate the effect of TAE226 treatment on renal fibrosis we stained kidney sections with antibodies specific for either fibronectin (to assess renal scarring) or CD11b (to assess for monocytic infiltration). This evidence concerns the gene ITGAM and renal fibrosis.